Timing of Radiation Pneumonitis in Patients with Stage 3 Non-Small-Cell Lung Cancer Receiving Consolidation Durvalumab after Chemoradiation

Melinda Mushonga; Alexander Louie; Susanna Cheng; May N. Tsao; Wee Loon Ong; Patrick Cheung; Ian Poon; L. Zhang; Yee C. Ung; Melinda Mushonga; Alexander Louie; Susanna Cheng; May N. Tsao; Wee Loon Ong; Patrick Cheung; Ian Poon; L. Zhang; Yee C. Ung

doi:10.1155/2024/5886423

HTML

Rights and permissions

Copyright: © 2024 by the author(s). Exclusive Licensee Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.

About this article

Cite this article

Melinda Mushonga, Alexander Louie, Susanna Cheng, May N. Tsao, Wee Loon Ong, Patrick Cheung, Ian Poon, L. Zhang, Yee C. Ung. 2024. Timing of Radiation Pneumonitis in Patients with Stage 3 Non-Small-Cell Lung Cancer Receiving Consolidation Durvalumab after Chemoradiation. European Journal of Cancer Care. 2024:5886423 doi: 10.1155/2024/5886423

Melinda Mushonga, Alexander Louie, Susanna Cheng, May N. Tsao, Wee Loon Ong, Patrick Cheung, Ian Poon, L. Zhang, Yee C. Ung. 2024. Timing of Radiation Pneumonitis in Patients with Stage 3 Non-Small-Cell Lung Cancer Receiving Consolidation Durvalumab after Chemoradiation. European Journal of Cancer Care. 2024:5886423 doi: 10.1155/2024/5886423

{{lists.name}}

Timing of Radiation Pneumonitis in Patients with Stage 3 Non-Small-Cell Lung Cancer Receiving Consolidation Durvalumab after Chemoradiation

Rights and permissions

About this article

Cite this article

Article Metrics

Access History

Other Articles By Authors